Background: β-Blockers are the most frequently prescribed cardioprotective drugs in hemodialysis (HD) patients, despite their weak evidence. We sought to evaluate the effects of β-blockers on vascular refilling during HD treatments and examine whether carvedilol, for being noncardioselective and poorly dialyzable, associates more impact than others.
Methods: The study was performed in a cohort of maintenance HD patients from a tertiary center. All patients had previous β-blocker prescription. We conducted a prospective crossover study and measured vascular refilling volume (Vref) and vascular refilling fraction (Fref) in 2 circumstances: under β-blocker treatment (βb profile) and without β-blocker effect (non-βb profile).
Results: Twenty patients were included, 10 of whom were treated with carvedilol. Predialysis values were comparable between the 2 profiles. Although the βb profile showed lower Vref and higher ABV drop, these differences did not reach statistical significance. Data showed an increase in Fref in the non-βb profile (70.01 ± 6.80% vs. 63.14 ± 11.65%; p = 0.015). The βb profile associated a significantly higher risk of intradialytic hypotension (IDH) (risk ratio 2.40; 95% CI: 1.04-5.55). When analyzing separately the carvedilol group, patients dialyzed under drug effect experienced a significant impairment in Vref, Fref, and refilling rate.
Conclusions: Administering β-blockers before HD associated a higher risk of IDH and a decrease in Fref. Patients dialyzed under carvedilol effect showed an impaired refilling, probably related to its noncardioselectivity and lower dializability.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1159/000519661 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Research Progress on the Measurement Methods and Clinical Significance of Capillary Refill Time.
Sensors (Basel)
December 2024
Beijing Tsinghua Changgung Hospital Affiliated to Tsinghua University, 168 Litang Road, Changping District, Beijing 102218, China.
The monitoring of peripheral circulation, as indicated by the capillary refill time, is a sensitive and accurate method of assessing the microcirculatory status of the body. It is a widely used tool for the evaluation of critically ill patients, the guidance of therapeutic interventions, and the assessment of prognosis. In recent years, there has been a growing emphasis on microcirculation monitoring which has led to an increased focus on capillary refill time.
View Article and Find Full Text PDFRefillable Drug Reservoirs for Retinal Vascular Diseases.
Am J Ophthalmol
November 2024
From California Retina Consultants (A.J.C., D.J.P.), San Luis Obispo, California. Electronic address:
Purpose: Most patients with retinal vascular disease require chronic, regular treatments to maximize visual potential. This places a challenging burden on the patient and is one reason why real-world visual outcomes often lag the results seen in clinical trials.
Methods: Sustained drug delivery devices have long been considered one way to alleviate this difficulty.
Relationships Among Capillary Refill Time, Peripheral Blood Flow Rate, and Fingertip Temperature: Advances in Peripheral Artery Contractility Diagnosis.
J Biomech Eng
February 2025
Department of Electrical and Mechanical Engineering, Graduate School of Engineering, Nagoya Institute of Technology, Gokiso-cho, Showa-ku, Nagoya 466-8555, Japan; Center of Biomedical Physics and Information Technology, Nagoya Institute of Technology, Gokiso-cho, Showa-ku, Nagoya 466-8555, Japan; Department of Nanopharmaceutical Sciences, Nagoya Institute of Technology, Gokiso-cho, Showa-ku, Nagoya 466-8555, Japan.
Capillary refill time (CRT) is a widely used noninvasive measure of cardiovascular health. Despite its widespread diagnostic utility, it has several limitations, particularly its low sensitivity for certain conditions, because factors such as the contraction and relaxation of distal blood vessels can influence CRT readings. This study was performed to explore the relationships between CRT and distal blood flow.
View Article and Find Full Text PDFPatient Preferences with Anti-Vascular Endothelial Growth Factor Treatment for Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema: A Multinational Discrete Choice Experiment Study.
Ophthalmic Res
December 2024
Genentech, Inc., South San Francisco, California, USA.
Introduction: New anti-vascular endothelial growth factor (VEGF) treatments are emerging for the treatment of diabetic macular edema (DME)/neovascular age-related macular degeneration (nAMD). This study aimed to explore the treatment attributes patients find important when deciding on treatment options.
Methods: This noninterventional survey study assessed treatment preferences through a discrete choice experiment (DCE) among patients with DME/nAMD in the USA, Canada, France, Italy, Spain, and the UK.
Predictors of intradialytic hypotension in critically ill patients undergoing kidney replacement therapy: a systematic review.
Intensive Care Med Exp
November 2024
Department of Critical Care, Hospital Israelita Albert Einstein, São Paulo, Brazil.
Article Synopsis
- This systematic review investigates predictors of intradialytic hypotension (IDH) in critically ill patients receiving kidney replacement therapy (KRT) for acute kidney injury (AKI).
- It analyzed data from 8 studies with 2873 patients, finding that machine learning models, particularly Extreme Gradient Boosting Machine (XGB) and deep neural networks (DNN), had the highest predictive accuracy compared to traditional indicators.
- The study emphasizes the need for combining predictive models and clinical indicators to enhance prediction of IDH and highlights that further validation in different healthcare settings is necessary.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!